Implantation of Add on Lens for Age Related Macular Degeneration Patients With Low Vision
NCT03061682 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2017-02-23
Summary
Age related macular degeneration (AMD) is the leading cause of vision loss in patients older than 55 years old. AMD can present as dry AMD or wet AMD. In most cases AMD affects both eyes although in many cases it's asymmetrical as far as severity. Some patients require low vision aids to continue their daily life tasks. In the past a few attempts were made to use low vision intraocular lenses with corrective glasses without enough success. In addition telescopic and prismatic lenses were also tried. The difficulties with these lenses included low field of vision, unsatisfactory magnification, complicated surgical technique and high complication rates.
Recently an add on lens was designed for the sulcus for implantation in pseudophakic AMD patients. The add on lens doubles the magnification of the central image dependent on the reading distance and the anatomy of the eye.
The lens is acrylic hydrophobic and designed for implantation in the sulcus either in pseudophakic patients or in addition to an intraocular lens implanted during a routine cataract surgery. The lens is 13 mm wide with 4 symmetric haptics. The lens has 1.5 mm central part of 10 diopters and the rest of the lens has no optical power.
Our purpose is to study implantation of the lenses in AMD patients to improve their reading ability and to improve their daily living.
Conditions
- Inclusion Criteria
Interventions
- DEVICE
-
"Scharioth" macula lens A45sml/A45smy
Implantation of an add on intraocular lens to low vision patients
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-01
- Primary Completion
- 2019-01-31
- Completion
- 2019-01-31
- FDA Device
- Yes
More Related Trials
-
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
NCT05438732 ·Status: RECRUITING ·Phase: NA
-
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
NCT01024998 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes
NCT01846351 ·Status: COMPLETED
-
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NCT06662162 ·Status: RECRUITING ·Phase: NA
-
Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
NCT03144999 ·Status: COMPLETED ·Phase: PHASE1
-
Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular Degeneration
NCT06174181 ·Status: COMPLETED ·Phase: NA
-
Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes
NCT04776031 ·Status: COMPLETED ·Phase: NA
-
OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD)
NCT04757610 ·Status: TERMINATED ·Phase: PHASE3
-
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD
NCT01016873 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing AR-13503 Implant in Subjects With nAMD or DME
NCT03835884 ·Status: COMPLETED ·Phase: PHASE1
-
ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
NCT01213082 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Carbidopa-Levodopa in Dry AMD With Geographic Atrophy
NCT03451500 ·Status: TERMINATED ·Phase: PHASE2
-
Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration
NCT04796545 ·Status: RECRUITING ·Phase: NA
-
Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT)
NCT05447650 ·Status: COMPLETED ·Phase: NA
-
A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular Degeneration
NCT00447954 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration
NCT02725762 ·Status: COMPLETED ·Phase: NA
-
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
NCT00877032 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection
NCT02713204 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
NCT03452527 ·Status: TERMINATED ·Phase: PHASE2
-
Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself
NCT00457678 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
NCT01255462 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)
NCT00056823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Non-exudative Age-related Macular Degeneration
NCT01712841 ·Status: COMPLETED
-
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
NCT02247531 ·Status: TERMINATED ·Phase: PHASE3
-
On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD)
NCT01670162 ·Status: UNKNOWN ·Phase: PHASE4